MedPath

Early Detection of Head and Neck Superficial Squamous Cell Carcinoma in Patients With Esophagus Squamous Cell Carcinoma

Not Applicable
Conditions
Optical Enhancement Endoscopy
Interventions
Device: first WLI
Device: first OE
Registration Number
NCT03700398
Lead Sponsor
Shandong University
Brief Summary

the investigators randomly divide the eligible objects into two groups:1. objects in this group will first receive OE endoscopy observation and subsequent white light imaging(WLI) observation during oropharynx and hypopharynx; 2. objects in this group will first receive WLI observation and subsequent OE observation during oropharynx and hypopharynx. Then, the investigators will compare the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma of two groups to find if OE endoscopy can improve the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma in esophageal cancer patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
214
Inclusion Criteria
  • order than 18 years old
  • Previous or current histopathological pathology confirmed the presence of esophageal squamous cell carcinoma
Read More
Exclusion Criteria
  • Previously confirmed pharynx/oropharyngeal squamous cell carcinoma
  • Advanced pharynx/hypopharyngeal squamous cell carcinoma
  • Pregnant women and lactating women
  • pharyngeal or esophageal stenosis, esophageal varices, or active digestive tract hemorrhage influence the observation or fail to obtain pathological diagnosis
  • Previous chemotherapy or radiation therapy affected observation
  • Not completed gastroscopy or refused to take biopsy for various reasons
  • Mental illnesses such as anxiety and depression affect the endoscopic observation
  • Severe systemic disease, can not tolerate gastroscopy
  • Refusal to sign informed consent books
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
First WLIfirst WLI-
first OEfirst OE-
Primary Outcome Measures
NameTimeMethod
detect rate12 months

the detect rate of oropharyngeal and hypopharyngeal superficial squamous cell carcinoma

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Qilu Hospital of Shandong University

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath